Showing: 1 - 10 of 10 RESULTS

New Game Changers in Medicine Episode About the Discovery of the X-Ray Premieres October 14

NEW YORK, Oct. 12, 2020 /PRNewswire/ — Game Changers in Medicine, the new monthly podcast from Dramatic Health, premieres its fourth episodeX-Rays: This invisible diagnostic light was born in the dark 125 years ago” on October 14, 2020. The use of radiation in medicine and dentistry revolutionized diagnostic techniques, and its applications went beyond the healthcare field to areas like airport security.  Produced by Dramatic Health co-founder and CEO Sean T. Moloney, the series is hosted by renowned medical futurist Dr. Rubin Pillay of the University of Alabama at Birmingham (UAB).

For details on the podcast series, visit www.gamechangersinmedicine.com 

The Dramatic Health and Game Changers in Medicine teams have gathered a distinguished group of experts to discuss the science and serendipity behind the discovery of the X-ray. Dr. Daniel Margolis, professor of radiology for Weill Cornell Medical College and the head of the department’s Prostate MRI program, is joined by Kathy Joseph, a physics teacher and historian who runs the up-and-coming YouTube channel, Kathy Loves Physics and History, on the history of scientific discoveries. Dr. David Rosenthal, professor of medicine at Harvard Medical School and former medical director and president of the Leonard P. Zakim Center for Integrated Therapies at the Dana-Farber Cancer Institute, is an advisor to the series. 

Dramatic Health, a national healthcare video company, is the producer of the six-part podcast series Game Changers in Medicine. Previous episodes have included: the premiere podcast about Vitamin K and an enterprising Boston house doctor; the creation of a smallpox vaccine and its parallels to today’s urgent search for a COVID-19 vaccine; and the history of the blood thinner warfarin, a rat poison turned game-changer in cardiology.  All episodes, a series backgrounder, and additional material about the podcast series are available at  www.gamechangersinmedicine.com and can be accessed wherever you find your podcasts.

Contact: Mark G. Auerbach. [email protected]

SOURCE Dramatic Health, Inc.

Source Article

U.S. daily COVID-19 cases remain above 50,000, Montana adds 5,000 cases in October

Oct. 11 (UPI) — New COVID-19 cases in the United States continued to rise at their highest rates since August amid surges in states like Montana.

The Johns Hopkins University global tracker reported 54,639 new cases and 618 deaths on Saturday, the fourth consecutive day with more than 50,000 deaths, a level of daily increase not seen since August.

Since the first reported case in the country on Jan. 21, the United States has reported world-leading totals of 7,745,951 cases and 214,641 deaths, according to Johns Hopkins data.

Johns Hopkins data showed that Montana has reported 5,046 COVID-19 cases from Sept. 30 through Oct. 10 after recording just 5,017 cases in the 150 days between its first reported case on March 13 and Aug. 10.

With 585 new cases Sunday, Montana has reported 18,702 total cases, up from 14,645 as of last Sunday, and a death toll of 210.

California, which leads the nation in COVID-19 cases, reported 3,803 new cases for a total of 846,579 while adding 64 deaths for a death toll of 16,564, which is second in the nation.

Texas reported the nation’s second-highest case total at 792,478, with an addition of 2,262, as well ass 16,557 deaths, including 31 new ones, in third ahead of New Jersey with 16,274.

Third place Florida tallied 5,570 new cases and 178 deaths over two days on Sunday after the state did not report data on Saturday while officials worked to strike hundreds of thousands of duplicate test results resent on Friday by Helix Laboratory, a private testing lab.

Sunday’s numbers brought Florida’s case total to 734,491 and its death toll to 15,364, which is fifth in the ntation.

In New York, Gov. Andrew Cuomo announced 1,143 new cases for the country’s fourth-highest total at 474,286, while adding five deaths to bring the nation’s leading death toll to 25,574 of confirmed deaths and 33,942 including probable deaths.

The state’s overall positivity reached 0.96% the first time it fell below 1% since Sept. 24. However, in “Red Zone” areas — which account for 2.8% of the state’s population but 14.9% of all positive tests — the positivity rate was 5.74%, while the rate for the rest of the state was 0.84%.

“We are taking strong action to respond to these outbreaks and to stop the spread. Mask up,” Cuomo wrote on Twitter.

No. 5 Georgia reported 1,162 new cases for a total of 331,409 and 23 new deaths, bringing its death toll to 7,416.

Sign up for our daily Top News Newsletter

Source Article

Coronavirus News Roundup, October 3-October 9

The items below are highlights from the free newsletter, “Smart, useful, science stuff about COVID-19.” To receive newsletter issues daily in your inbox, sign up here.

David Tuller at Kaiser Health News reports that saliva tests for SARS-CoV-2 are catching on in the U.S., but only represent a “small percentage of the more than 900,000 tests conducted daily on average at the end of September.” A University of Illinois chemist quoted in the 10/6/20 story says of saliva tests, “You don’t need swabs, you don’t need health care workers, you don’t need [chemicals to stabilize spit-samples], and you don’t need RNA isolation [extraction] kits.”

Meanwhile, two companies have abandoned each of their efforts to develop at-home saliva tests for SARS-CoV-2 antigens (antigen tests look for viral proteins or structures that provoke an immune response, not for pieces of the virus’s genetic material, like the tests in previous item), reports Katherine J. Wu at The New York Times (10/1/20). The story describes various ongoing efforts to develop saliva tests for the virus. “There’s still no consensus on how well saliva works for detecting the coronavirus compared with the fluids obtained by nose swabs,” Wu writes.

A project called covidestim out of the the Yale School of Public Health publishes an interactive visualization of new SARS-CoV-2 infections in the U.S. per 100,000 people over time. A reader drew my attention to a 10/1/20 tweet about the project by Howard Forman of the Yale School of Management. Updated daily based on a statistical model that yields real-time estimates of the epidemic’s spread in the U.S., the dark purple areas on the page’s U.S. map show low infection rates, while the brighter orange and yellow areas have higher infection rates. Forman writes that the map shows “how small areas matter more than geographic or political boundaries. There are hot and warm spots in most states.” The page also features graphs illustrating infections per 100,000 and estimated infection counts for each U.S. state over time, from mid-March to the present.

Adults aged 65 to 80 are most affected by COVID-19 but older adults are excluded from more than half of Phase 3 experiments on possible vaccines and treatments for COVID-19, concludes a study published 9/28/20 in JAMA Internal Medicine that Pratibha Gopalakrishna covered 9/30/20 at STAT. The analysis focuses on experiments indexed on Clinicaltrials.gov, a registry for experimental drug and treatment studies that are funded by the U.S. National Institutes of Health among others.

Results published in the New England Journal of Medicine show that Moderna’s vaccine against SARS-CoV-2 appears to be safe in older adults and provokes an immune response similar to that seen in younger adults, reports Julie Steenhuysen at Reuters (10/1/20). The safety study, an extension of Moderna’s Phase 1 vaccine experiment, involved “40 adults aged 56 to 70 and 71 and older,” Steenhuysen writes. A high-dose version of the vaccine candidate currently is undergoing a Phase 3 study to assess effectiveness and safety, the story states. Phase 3 studies

Humble ISD prepares volleyball, football events to bring awareness to breast cancer in October

With breast cancer awareness month beginning in October, the Humble ISD athletics department will do their part in the fight to bring awareness to the battle against the deadly disease.

Across the district, several sports will hold special games dedicated to cancer survivors, people fighting cancer and the people that have been lost.

Volleyball teams throughout the month of October will have matches raising money and awareness for breast cancer. Humble ISD has donated all proceeds in the past to the American Cancer Society.


Kingwood Park’s famous Dig Pink at the Park game will be back to raise money for breast cancer on Oct. 20 against Porter at 6:30 p.m.

Schools will hold raffles during volleyball matches to raises money and schools will also make T-shirts as well to donate to charities.

During volleyball matches players will wear pink on their uniforms from hair ties, to knee pads, and even bracelets while the whole crowd is covered with pink.

People are asked to stand and be recognized during the match for those who are cancer survivors and are give standing ovations by the crowd.

The district will also celebrate breast cancer awareness at Turner Stadium during the football season as well in October.

The District 21-6A contest between North Shore and Humble at 7 p.m. Oct. 29 has been named the Breast Cancer Awareness game of the season.

Football players will wear pink on their uniforms whether it’s a towel, gloves, or socks. Cancer survivors, people fighting cancer and the lives that have been lost to cancer will be recognized along with fans in the stands.

Players will wear pink throughout the month of October to honor and bring awareness to breasts cancer during football games at Turner Stadium.

[email protected]

Twitter:@MarcG14Line

Source Article

The best cheap fitness tracker deals for October 2020: Garmin, Fitbit and more



a hand holding a watch: The best fitness tracker deals image 1


© Provided by Pocket-lint
The best fitness tracker deals image 1

(Pocket-lint) – If you’re in the market for a new tracker or smartwatch, then you’re in the right place, as we’re covering the top offers on some of the best fitness devices out there.

There great savings are from well-known and popular brands such as Fitbit, Garmin and Samsung, and with Prime Day 2020 soon to be on us, we’re expecting a lot more deals over the coming weeks. 

Garmin Fenix 5

  • Great for the outdoors
  • Long battery life
  • Accurate

The Fenix is the top tier of Garmin devices, offering accurate tracking in all conditions. It’s designed to be a little tougher and last a little longer than the top Forerunner devices. The Fenix 5 is a little older, but that’s why there’s usually good deals to be had on it.

Fitbit Inspire

  • Slim and stylish design
  • Sleep tracking
  • Great for tweens

The Fitbit Inspire replaced the Alta and offers step and activity tracking in a fitness band. This entry-level model lacks some the heart rate tracking that you get on the model up, but it’s great for tracking daily activity while also giving you smartphone notifications. It will also offer sleep tracking, so it’s great for younger users.

Garmin Forerunner 35

  • Accurate fitness tracking
  • Strong battery life
  • Reliable heart rate sensor

If you’re looking for an entry into the world of running watches then the Garmin Forerunner 35 is a watch that tunes itself brilliantly to the rigours and requirements of a dedicated running watch. It’s a little older, but still a reliable option for those who want to track their running with GPS and heart rate.

Garmin Vivoactive 3

  • Accurate activity tracking
  • Lifestyle focused

With a slightly slicker design that some of the Forerunner models, the Vivoactive is aimed at lifestyle users rather than hardcore athletes. That means it has a touchscreen interface, but it still uses the same core tracking skills and sensors. That means it’s just as accurate as many of the top Garmin devices, but slightly more approachable.

Other fitness tracker deals

Not seeing a good bargain above? Feel free to use the quick retailer links below to to find your idea deal.

Source Article

Why an October Vaccine Wouldn’t Swing the Election for Trump

President Donald Trump has promised that a safe and effective vaccine against the novel coronavirus causing COVID-19 will be rolled out in October, with 100 million doses available by the end of the year. In Tuesday’s presidential debate, he reaffirmed that the vaccine was just “weeks away.” Yet this announcement contradicts the estimations of scientists, public health experts and, most recently, the director of the Centers for Disease Control and Prevention.



Donald Trump that is standing in the grass: President Donald exits Marine One on the South Lawn of the White House on October 1 in Washington, D.C.


© Getty/Drew Angerer
President Donald exits Marine One on the South Lawn of the White House on October 1 in Washington, D.C.

CDC Director Robert Redfield explained to a Senate panel this month that a vaccine would be “generally available to the American public, so we can begin to take advantage of vaccine to get back to our regular life” sometime in mid- to late-2021. Trump was quick to dismiss Redfield as mistaken and “confused,” and reiterated his continued confidence in the vaccine’s rollout in the very near future.

Loading...

Load Error

But how likely is that to happen, and, if it did, would it really shake up the presidential race?

The promise of an “October surprise”—that is, a late-breaking revelation so big that it could shift the results of an election—sounds enticing. The term was first used to describe the possibility that the Ronald Reagan campaign had conspired with Iran to keep American hostages from being released in time to save Jimmy Carter’s 1980 re-election bid.

But the reality is that very little, including a vaccine, is likely to make much of an impact in this election.

Producing a safe and effective vaccine for a disease within a year of that disease’s discovery would be unprecedented. Even if “Operation Warp Speed,” Trump’s initiative to streamline the vaccine development, approval and distribution process, is successful, the number of things that would have to go right for a vaccine to roll out successfully this year makes the goal highly unlikely. We would need to see tens of thousands people enroll in clinical trials and receive two doses of a vaccine (or a placebo) a month apart, have data that show safety and efficacy (meaning that that the vaccine prevents infection or severity of illness in at least 50 percent of participants who received the vaccine) and observe a lack of serious side effects.

First Presidential Debate 2020 Highlights: Biden, Trump’s Chaotic Sparring As Wallace Tries To Control

UP NEXT

UP NEXT

Given that none of the nine companies in Phase 3 trials have completed enrollment and all have jointly pledged to “stand with science” and not apply for licensing of any vaccine that has not been thoroughly vetted for safety and efficacy, Trump’s goal seems unrealistic.

Vaccine success depends on the willingness of millions of people to get it. This requires a good deal of public trust, both in the companies and procedures that produce it and in the government agencies that certify it. Trump, however, has poisoned that well by repeatedly undermining public trust in government agencies and processes

New coronavirus testing site coming to Elkridge; additional locations announced at churches through October

A new coronavirus testing site in Elkridge will open later this month, Howard County announced this week.

Quality First Urgent Care is opening a drive-thru testing site at the Elkridge Volunteer Fire Department, 5700 Rowanberry Drive, according to a county news release.

The site will open Oct. 12 and will be operated from 8:30 a.m. to 4:30 p.m. Monday through Thursday.

“As part of the public safety team in Howard County, it is imperative that we support the response to the COVID-19 pandemic,” fire Chief William Anuszewski said in a statement. “The ability to assist with a feasible location for COVID-19 testing without impacting our ability to continue providing quality emergency service is a win-win for the community we serve.”

A doctor’s order will not be required at the site. Appointments can be made ahead of time, but they are not required.

“Opening a testing site in the northern part of the county allows more residents to conveniently obtain testing near them,” Howard County Health Officer Dr. Maura Rossman said in a statement. “The more people who are tested and are aware of their COVID status, the more effective we can be at controlling the spread of the virus.”

The announcement comes a week after the closing of the COVID-19 testing site at the Vehicle Emissions Inspection Program location in Columbia. The VEIP site stopped serving as a testing site in order to allow the emissions location to resume regular operations, according to the county.

Howard County General Hospital also released additional community testing sites for the month of October:

8 a.m. to noon Saturday — First Baptist Church of Guilford, 7504 Oakland Mills Road, Columbia

8 a.m. to 12:30 p.m. Oct. 10 — Church of Jesus Christ of Latter-day Saints, 4100 St. John’s Lane, Ellicott City

8 a.m. to 12:30 p.m. Oct. 25 — Church of Jesus Christ of Latter-day Saints, 6020 Ten Oaks Road, Clarksville

10 a.m. to 2 p.m. Oct. 31 — Celebration Church, 7101 Riverwood Drive, Columbia

Advance registration is encouraged at bit.ly/j2bh-testing.

Other testing sites in Howard County include:

Howard County General Hospital (drive-thru, appointment/doctor’s order required), 5755 Cedar Lane, Columbia: 9 a.m. to 5 p.m. Monday through Friday

Quality First Urgent Care (drive-thru), Savage Volunteer Fire Company, 8521 Corridor Road: 8 a.m. to 8 p.m. Monday through Friday, 8 a.m. to 2 p.m. Saturday

Quality First Urgent Care (drive-thru), Elkridge Volunteer Fire Department, 5700 Rowanberry Drive: 8:30 a.m. to 4:30 p.m. Monday through Thursday, starting Oct. 12

OUCH! Urgent Care, 6020 Meadowridge Center Drive, Suite F, Elkridge: 8 a.m. to 6:30 p.m. Monday through Sunday

Righttime Medical Care Urgent Care, 6334 Cedar Lane, Columbia: 6 a.m. to 8 p.m. Monday through Sunday

First Call Urgent Care Center/Centennial Medical Group, 10981 Johns Hopkins Road, Laurel: 8 a.m. to 9 p.m. Monday through Friday

All Care Urgent Care (drive-thru, appointment required), 9396 Baltimore National Pike, Ellicott City: 8 a.m. to 8 p.m. Monday through Friday, 8 a.m. to 4 p.m. Saturday, 9 a.m. to

450 New Coronavirus Cases Reported In Virginia As October Begins

VIRGINIA — To start the month of October, the Virginia Department of Health coronavirus dashboard showed one of the lower new case totals in recent months. On Thursday, 450 new cases were reported, bringing the cumulative case total to 148,721.

The breakdown of new cases by region is 147 in the southwest region, 121 in the northwest region, 71 in the northern region, 60 in the eastern region, and 51 in the central region. The seven-day average of new cases across Virginia is now 747, compared to 997 on Sept. 1.

The positive average of PCR tests remains at 4.5 percent, below the 5 percent rate recommended by the World Health Organization before reopening. Four regions have averages in the 4-percent range — the northwest and eastern regions with 4.4 percent, northern region with 4.3 percent and central region with 4.1 percent. The southwest region has an average above the statewide average — 5.7 percent. The total of PCR tests completed in Virginia stands at 2,074,236, up 24,248 from Wednesday.

Hospitalizations of COVID-19 patients stand at 913 statewide on Thursday. The breakdown of hospital patients by region is 282 in the central region, 199 in the northern region, 178 in the eastern region, 168 in the southwest region, and 86 in the northwest region.

The current hospitalizations include 210 in the intensive care units and 107 on ventilators, according to the Virginia Hospital & Healthcare Association. Ventilator use stands at 20 percent among all Virginia patients, and ICU occupancy remains at 79 percent. There are no hospitals reporting difficulty obtaining personal protective equipment in the next 72 hours.

Here is the latest breakdown of cases, hospitalizations and deaths by age group:

  • Ages 0-9: 5,452 cases, 93 hospitalizations, 0 deaths

  • 10-19: 14,557 cases, 120 hospitalizations, 1 death

  • 20-29: 30,950 cases, 472 hospitalizations, 7 deaths

  • 30-39: 25,471 cases, 961 hospitalizations, 29 deaths

  • 40-49: 22,941 cases, 1,427 hospitalizations, 87 deaths

  • 50-59: 20,816 cases, 2,037 hospitalizations, 223 deaths

  • 60-69: 13,616 cases, 2,218 hospitalizations, 506 deaths

  • 70-79: 7,226 cases, 1,938 hospitalizations, 820 deaths

  • 80 and up: 6,441 cases, 1,807 hospitalizations, 1,551 deaths

  • Not reported: 1,251 cases, 19 hospitalizations, 4 deaths

Here are the latest coronavirus data updates for our coverage area between Tuesday and Wednesday:

  • Alexandria: 3,859 cases, 324 hospitalizations, 69 deaths; increase of seven cases and one hospitalization

  • Arlington County: 3,997 cases, 500 hospitalizations, 150 deaths; increase of two cases

  • Fairfax County: 21,018 cases, 2,166 hospitalizations, 588 deaths; increase of 37 cases and six hospitalizations

  • Fairfax City: 137 cases, 14 hospitalizations, eight deaths; no changes

  • Falls Church: 71 cases, 13 hospitalizations, seven deaths; increase of one case

  • Loudoun County: 6,887 cases, 436 hospitalizations, 126 deaths; two cases removed, increase of one hospitalization and one death

  • Manassas: 1,931 cases, 130 hospitalizations, 26 deaths; no changes

  • Manassas Park: 613 cases, 55 hospitalizations, eight deaths; one case removed

  • Prince William County: 12,594 cases, 919 hospitalizations, 207 deaths; increase of 27 cases, four hospitalizations and two deaths

  • Fredericksburg: 549 cases, 49 hospitalizations, five deaths; increase of

The Latest: US extends ban on cruise ships through October

WASHINGTON — Federal health officials are extending the U.S. ban on cruise ships through the end of October amid reports of recent outbreaks of the new coronavirus on ships overseas.

The Centers for Disease Control and Prevention announced Wednesday that it was extending a no-sail order on cruise ships with the capacity to carry at least 250 passengers.

The CDC said surveillance data from March 1 through Sept. 29 shows at least 3,689 COVID-19 or COVID-like illnesses on cruise ships in U.S. waters, in addition to at least 41 reported deaths. It said these numbers are likely an underestimate.

It cited recent outbreaks as evidence that cruise ship travel continues to transmit and amplify the spread of the novel coronavirus, even when ships sail at reduced passenger capacities. It said it would likely spread the infection in the U.S. communities if operations were to resume prematurely.

“Recent passenger voyages in foreign countries continue to have outbreaks, despite cruise ship operators having extensive health and safety protocols to prevent the transmission of SARS-CoV-2 on board and spread to communities where passengers disembark,” the CDC said in a statement.

———

HERE’S WHAT YOU NEED TO KNOW ABOUT THE VIRUS OUTBREAK

— UK lawmakers grumble but renew sweeping govt virus powers

— Wisconsin hospitals filling with patients as virus surges

— Virus outbreak pushes NFL’s Steelers-Titans game to Monday or Tuesday

— Scientists are starting to unravel one of COVID-19′s scariest mysteries: Why are some people only mildly ill or have no symptoms and others rapidly die.

— The coronavirus pandemic has put a damper on student life across the globe. But in Brussels, the Belgian capital is using its famous Grand-Place square for graduation ceremonies of two universities.

— Scores of actors, technicians and theater staff marched through London’s West End to Parliament to the beat of showtunes, asking for plan to revive the arts.

———

Follow AP’s pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak

———

HERE’S WHAT ELSE IS HAPPENING:

SINGAPORE — Singapore will allow entry to travelers from Vietnam and Australia, excluding its coronavirus hot spot Victoria state, beginning next week.

The tiny city-state last month welcomed visitors from Brunei and New Zealand, and is cautiously reopening its borders after a virus closure to help revive its airport, a key regional aviation hub.

The aviation authority has said there is a low risk of virus importation from the two countries. Travelers must undergo a virus swab test upon arrival, travel on direct flights without transit and download a mobile app for contact tracing.

The Vietnam and Australia changes start from Oct. 8.

Singapore’s move is unilateral and not reciprocated by the other four countries.

But Transport Minister Ong Ye Kung said in a Facebook post Wednesday that “with each step of safe opening of our borders, we start to rebuild the bridges and resuscitate Changi Airport.”

Singapore has managed to control the pandemic after an earlier upsurge due to infections among foreign workers living in packed dormitories. It has confirmed more

Will Pfizer’s Vaccine Be Ready in October? Here’s Why That’s Unlikely.

In media appearances and talks with investors, Pfizer’s chief executive nearly always mentions a word that is so politically perilous, most of his competitors shy away from it: October.

“Right now, our model — our best case — predicts that we will have an answer by the end of October,” the chief executive, Dr. Albert Bourla, told the “Today” show earlier this month. In other interviews, he has said he expected a “conclusive readout” by then, with an application for emergency authorization that could be filed “immediately.”

Dr. Bourla’s statements have put his company squarely in the sights of President Trump, who has made no secret of his desire for positive vaccine news to boost his chances on Election Day, Nov. 3. “We’re going to have a vaccine very soon. Maybe even before a very special date,” Mr. Trump said recently.

And yet by all other accounts, the idea that it will be ready in October is far-fetched. Even if the vaccine shows promising signs in clinical trials — still a big if — the company will not have collected enough data by then to say with any statistical confidence that it is safe and effective.

By repeating a date that flies in the face of most scientific predictions, Dr. Bourla is making a high-stakes gamble. If Pfizer puts out a vaccine before it has been thoroughly tested — something the company has pledged it will not do — it could pose a major threat to public safety. The perception matters, too: If Americans see the vaccine as having been rushed in order to placate Mr. Trump, many may refuse to get the shot.

But there is a significant upside, to the tune of billions of dollars, in being first to the U.S. market with a vaccine. And staying in the president’s good graces — particularly when he keeps talking about ways to lower drug prices — might not be a bad thing for a company that brought in nearly $40 billion in 2019 from sales of high-priced, brand-name drugs.

“There’s a huge financial advantage to being first out of the gate,” said Dr. Megan Ranney, an associate professor of emergency medicine and public health at Brown University. She was one of 60 public health officials and others in the medical community who signed a letter to Pfizer urging it not to rush its vaccine.

And given the White House’s persistent efforts to interfere in the decisions of federal health agencies, some scientists fear a vaccine approval could come under similar pressure.

“What I worry about is that the politics or the financial gain may drive earlier release than is scientifically appropriate,” Dr. Ranney said.

Pfizer will not be anywhere near completion of its clinical trial by the end of October, according to a company spokeswoman. When Dr. Bourla referred to a “conclusive readout” next month, she said, he meant that it’s possible the outside board of experts monitoring the trial would have by that date found promising signs that